United Therapeutics is at its lowest price in more than 10 months, and one investor is betting against a quick rebound.
optionMONSTER's tracking systems detected the sale of more than 4,100 August 55 calls for $0.50 and the purchase of an equal number of September 55 calls for $3.10, resulting in a cost of $2.60. Volume was above open interest in both strikes.
Known as a calendar spread, the trade is designed to profit from the August contracts losing value at a quicker pace than the September options. He or she may also expect a rebound after August expiration, in which case they'll stand to profit because of the long position in the longer-dated calls. (See our Education section)
UTHR fell 3.39 percent to $49.05 yesterday and has lost one-quarter of its value in the last three months. The company attempted to rally after earnings and revenue beat forecasts on July 28, but it's still fighting a downdraft from early June when trial results on the pulmonary hypertension drug oral Remodulin disappointed investors.
Overall options volume in the name was 7 times greater than average in the session.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright © 2010 OptionMonster® Holdings, Inc. All Rights Reserved.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
